Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

Strategies for intranasal delivery of vaccines.

Zaman M, Chandrudu S, Toth I.

Drug Deliv Transl Res. 2013 Feb;3(1):100-9. doi: 10.1007/s13346-012-0085-z. Epub 2012 Jul 12.

2.

Nasal and pulmonary vaccine delivery using particulate carriers.

Jia Y, Krishnan L, Omri A.

Expert Opin Drug Deliv. 2015 Jun;12(6):993-1008. doi: 10.1517/17425247.2015.1044435. Epub 2015 May 8. Review.

PMID:
25952104
3.

Nasal delivery of vaccines.

Almeida AJ, Alpar HO.

J Drug Target. 1996;3(6):455-67. Review.

PMID:
8863138
4.

Intranasal formulations: promising strategy to deliver vaccines.

Riese P, Sakthivel P, Trittel S, Guzmán CA.

Expert Opin Drug Deliv. 2014 Oct;11(10):1619-34. doi: 10.1517/17425247.2014.931936. Epub 2014 Jun 25. Review.

PMID:
24962722
5.
6.

Mechanisms of vaccine adjuvanticity at mucosal surfaces.

Foss DL, Murtaugh MP.

Anim Health Res Rev. 2000 Jun;1(1):3-24. Review.

PMID:
11706842
7.

Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.

Lawson LB, Norton EB, Clements JD.

Curr Opin Immunol. 2011 Jun;23(3):414-20. doi: 10.1016/j.coi.2011.03.009. Epub 2011 Apr 19. Review.

PMID:
21511452
8.

Mucosal immunization: a review of strategies and challenges.

Patel H, Yewale C, Rathi MN, Misra A.

Crit Rev Ther Drug Carrier Syst. 2014;31(4):273-303. Review.

PMID:
25072196
9.

Mucosal vaccines: where do we stand?

Kraehenbuhl JP, Neutra MR.

Curr Top Med Chem. 2013;13(20):2609-28. Review.

PMID:
24066889
10.

Delivery systems: a vaccine strategy for overcoming mucosal tolerance?

Mann JF, Acevedo R, Campo JD, Pérez O, Ferro VA.

Expert Rev Vaccines. 2009 Jan;8(1):103-12. doi: 10.1586/14760584.8.1.103. Review.

PMID:
19093777
11.

Mucosal responses to parenteral and mucosal vaccines.

Kaul D, Ogra PL.

Dev Biol Stand. 1998;95:141-6. Review.

PMID:
9855424
12.

Archaeal lipid mucosal vaccine adjuvant and delivery system.

Patel GB, Chen W.

Expert Rev Vaccines. 2010 Apr;9(4):431-40. doi: 10.1586/erv.10.34. Review.

PMID:
20370552
13.

Approaches to tuberculosis mucosal vaccine development using nanoparticles and microparticles: a review.

Caetano LA, Almeida AJ, Gonćalves LM.

J Biomed Nanotechnol. 2014 Sep;10(9):2295-316. Review.

PMID:
25992458
14.

Chitosan for mucosal vaccination.

van der Lubben IM, Verhoef JC, Borchard G, Junginger HE.

Adv Drug Deliv Rev. 2001 Nov 5;52(2):139-44. Review.

PMID:
11718937
15.

Recent advances in mucosal vaccine development.

Chen H.

J Control Release. 2000 Jul 3;67(2-3):117-28. Review.

PMID:
10825547
16.

Bioadhesive delivery systems for mucosal vaccine delivery.

Baudner BC, O'Hagan DT.

J Drug Target. 2010 Dec;18(10):752-70. doi: 10.3109/1061186X.2010.529143. Epub 2010 Nov 2. Review.

PMID:
21039314
17.

Buccal and sublingual vaccine delivery.

Kraan H, Vrieling H, Czerkinsky C, Jiskoot W, Kersten G, Amorij JP.

J Control Release. 2014 Sep 28;190:580-92. doi: 10.1016/j.jconrel.2014.05.060. Epub 2014 Jun 6. Review.

18.

Microparticles as vaccine adjuvants and delivery systems.

O'Hagan DT, Singh M.

Expert Rev Vaccines. 2003 Apr;2(2):269-83. Review.

PMID:
12899577
19.

[The development of mucosal vaccine using bacterial function for targeting mucosal tissues].

Suzuki H, Kondoh M, Yagi K, Kiyono H, Kunisawa J.

Yakugaku Zasshi. 2014;134(5):629-34. Review. Japanese.

20.

Novel strategies using DNA for the induction of mucosal immunity.

McCluskie MJ, Davis HL.

Crit Rev Immunol. 1999;19(4):303-29. Review.

PMID:
10530431

Supplemental Content

Support Center